तुलना करने के लिए मीट्रिक्स | NXL | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधNXLपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | −1.2x | −2.8x | −0.4x | |
PEG अनुपात | −0.03 | −0.08 | 0.00 | |
क़ीमत/बुक | 3.4x | 5.1x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 35.3x | 2.8x | 3.1x | |
अपसाइड (विश्लेषक लक्ष्य) | 326.4% | 52.1% | 50.8% | |
उचित मूल्य अपसाइड | अनलॉक करें | 4.8% | 7.8% | अनलॉक करें |
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer’s disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.